[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sevoflurane Anesthesia Drugs Market Growth 2024-2030

November 2024 | 95 pages | ID: G3C2FF042F0EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Sevoflurane is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

The global Sevoflurane Anesthesia Drugs market size is projected to grow from US$ 1169 million in 2024 to US$ 1458 million in 2030; it is expected to grow at a CAGR of 3.8% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Sevoflurane Anesthesia Drugs Industry Forecast” looks at past sales and reviews total world Sevoflurane Anesthesia Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Sevoflurane Anesthesia Drugs sales for 2024 through 2030. With Sevoflurane Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane Anesthesia Drugs industry.

This Insight Report provides a comprehensive analysis of the global Sevoflurane Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sevoflurane Anesthesia Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane Anesthesia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane Anesthesia Drugs.

United States market for Sevoflurane Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Sevoflurane Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Sevoflurane Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Sevoflurane Anesthesia Drugs players cover Hengrui, Baxter, Maruishi, AbbVie, Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Generic Drugs
  • Brand Drug
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Hengrui
  • Baxter
  • Maruishi
  • AbbVie
  • Piramal
  • LAB UNKNOWN
  • Viatris
  • PT Novell Pharmaceutical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Sevoflurane Anesthesia Drugs market?

What factors are driving Sevoflurane Anesthesia Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sevoflurane Anesthesia Drugs market opportunities vary by end market size?

How does Sevoflurane Anesthesia Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sevoflurane Anesthesia Drugs Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Sevoflurane Anesthesia Drugs by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Sevoflurane Anesthesia Drugs by Country/Region, 2019, 2023 & 2030
2.2 Sevoflurane Anesthesia Drugs Segment by Type
  2.2.1 Generic Drugs
  2.2.2 Brand Drug
2.3 Sevoflurane Anesthesia Drugs Sales by Type
  2.3.1 Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2024)
  2.3.2 Global Sevoflurane Anesthesia Drugs Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Sevoflurane Anesthesia Drugs Sale Price by Type (2019-2024)
2.4 Sevoflurane Anesthesia Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Sevoflurane Anesthesia Drugs Sales by Application
  2.5.1 Global Sevoflurane Anesthesia Drugs Sale Market Share by Application (2019-2024)
  2.5.2 Global Sevoflurane Anesthesia Drugs Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Sevoflurane Anesthesia Drugs Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Sevoflurane Anesthesia Drugs Breakdown Data by Company
  3.1.1 Global Sevoflurane Anesthesia Drugs Annual Sales by Company (2019-2024)
  3.1.2 Global Sevoflurane Anesthesia Drugs Sales Market Share by Company (2019-2024)
3.2 Global Sevoflurane Anesthesia Drugs Annual Revenue by Company (2019-2024)
  3.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Company (2019-2024)
  3.2.2 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Sevoflurane Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers Sevoflurane Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Sevoflurane Anesthesia Drugs Product Location Distribution
  3.4.2 Players Sevoflurane Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SEVOFLURANE ANESTHESIA DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Sevoflurane Anesthesia Drugs Market Size by Geographic Region (2019-2024)
  4.1.1 Global Sevoflurane Anesthesia Drugs Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Sevoflurane Anesthesia Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Sevoflurane Anesthesia Drugs Market Size by Country/Region (2019-2024)
  4.2.1 Global Sevoflurane Anesthesia Drugs Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Sevoflurane Anesthesia Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sevoflurane Anesthesia Drugs Sales Growth
4.4 APAC Sevoflurane Anesthesia Drugs Sales Growth
4.5 Europe Sevoflurane Anesthesia Drugs Sales Growth
4.6 Middle East & Africa Sevoflurane Anesthesia Drugs Sales Growth

5 AMERICAS

5.1 Americas Sevoflurane Anesthesia Drugs Sales by Country
  5.1.1 Americas Sevoflurane Anesthesia Drugs Sales by Country (2019-2024)
  5.1.2 Americas Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024)
5.2 Americas Sevoflurane Anesthesia Drugs Sales by Type (2019-2024)
5.3 Americas Sevoflurane Anesthesia Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sevoflurane Anesthesia Drugs Sales by Region
  6.1.1 APAC Sevoflurane Anesthesia Drugs Sales by Region (2019-2024)
  6.1.2 APAC Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024)
6.2 APAC Sevoflurane Anesthesia Drugs Sales by Type (2019-2024)
6.3 APAC Sevoflurane Anesthesia Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Sevoflurane Anesthesia Drugs by Country
  7.1.1 Europe Sevoflurane Anesthesia Drugs Sales by Country (2019-2024)
  7.1.2 Europe Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024)
7.2 Europe Sevoflurane Anesthesia Drugs Sales by Type (2019-2024)
7.3 Europe Sevoflurane Anesthesia Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sevoflurane Anesthesia Drugs by Country
  8.1.1 Middle East & Africa Sevoflurane Anesthesia Drugs Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Sevoflurane Anesthesia Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Sevoflurane Anesthesia Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sevoflurane Anesthesia Drugs
10.3 Manufacturing Process Analysis of Sevoflurane Anesthesia Drugs
10.4 Industry Chain Structure of Sevoflurane Anesthesia Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Sevoflurane Anesthesia Drugs Distributors
11.3 Sevoflurane Anesthesia Drugs Customer

12 WORLD FORECAST REVIEW FOR SEVOFLURANE ANESTHESIA DRUGS BY GEOGRAPHIC REGION

12.1 Global Sevoflurane Anesthesia Drugs Market Size Forecast by Region
  12.1.1 Global Sevoflurane Anesthesia Drugs Forecast by Region (2025-2030)
  12.1.2 Global Sevoflurane Anesthesia Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Sevoflurane Anesthesia Drugs Forecast by Type (2025-2030)
12.7 Global Sevoflurane Anesthesia Drugs Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Hengrui
  13.1.1 Hengrui Company Information
  13.1.2 Hengrui Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.1.3 Hengrui Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Hengrui Main Business Overview
  13.1.5 Hengrui Latest Developments
13.2 Baxter
  13.2.1 Baxter Company Information
  13.2.2 Baxter Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.2.3 Baxter Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Baxter Main Business Overview
  13.2.5 Baxter Latest Developments
13.3 Maruishi
  13.3.1 Maruishi Company Information
  13.3.2 Maruishi Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.3.3 Maruishi Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Maruishi Main Business Overview
  13.3.5 Maruishi Latest Developments
13.4 AbbVie
  13.4.1 AbbVie Company Information
  13.4.2 AbbVie Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.4.3 AbbVie Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 AbbVie Main Business Overview
  13.4.5 AbbVie Latest Developments
13.5 Piramal
  13.5.1 Piramal Company Information
  13.5.2 Piramal Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.5.3 Piramal Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Piramal Main Business Overview
  13.5.5 Piramal Latest Developments
13.6 LAB UNKNOWN
  13.6.1 LAB UNKNOWN Company Information
  13.6.2 LAB UNKNOWN Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.6.3 LAB UNKNOWN Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 LAB UNKNOWN Main Business Overview
  13.6.5 LAB UNKNOWN Latest Developments
13.7 Viatris
  13.7.1 Viatris Company Information
  13.7.2 Viatris Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.7.3 Viatris Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Viatris Main Business Overview
  13.7.5 Viatris Latest Developments
13.8 PT Novell Pharmaceutical
  13.8.1 PT Novell Pharmaceutical Company Information
  13.8.2 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
  13.8.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 PT Novell Pharmaceutical Main Business Overview
  13.8.5 PT Novell Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES
.
Table 1. Sevoflurane Anesthesia Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Sevoflurane Anesthesia Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Brand Drug
Table 5. Global Sevoflurane Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 6. Global Sevoflurane Anesthesia Drugs Sales Market Share byType (2019-2024)
Table 7. Global Sevoflurane Anesthesia Drugs Revenue byType (2019-2024) & ($ million)
Table 8. Global Sevoflurane Anesthesia Drugs Revenue Market Share byType (2019-2024)
Table 9. Global Sevoflurane Anesthesia Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 10. Global Sevoflurane Anesthesia Drugs Sale by Application (2019-2024) & (K Units)
Table 11. Global Sevoflurane Anesthesia Drugs Sale Market Share by Application (2019-2024)
Table 12. Global Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & ($ million)
Table 13. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2024)
Table 14. Global Sevoflurane Anesthesia Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Sevoflurane Anesthesia Drugs Sales by Company (2019-2024) & (K Units)
Table 16. Global Sevoflurane Anesthesia Drugs Sales Market Share by Company (2019-2024)
Table 17. Global Sevoflurane Anesthesia Drugs Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Company (2019-2024)
Table 19. Global Sevoflurane Anesthesia Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Sevoflurane Anesthesia Drugs Producing Area Distribution and Sales Area
Table 21. Players Sevoflurane Anesthesia Drugs Products Offered
Table 22. Sevoflurane Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sevoflurane Anesthesia Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Sevoflurane Anesthesia Drugs Sales Market Share Geographic Region (2019-2024)
Table 27. Global Sevoflurane Anesthesia Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Sevoflurane Anesthesia Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Sevoflurane Anesthesia Drugs Sales Market Share by Country/Region (2019-2024)
Table 31. Global Sevoflurane Anesthesia Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 34. Americas Sevoflurane Anesthesia Drugs Sales Market Share by Country (2019-2024)
Table 35. Americas Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Sevoflurane Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 37. Americas Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 38. APAC Sevoflurane Anesthesia Drugs Sales by Region (2019-2024) & (K Units)
Table 39. APAC Sevoflurane Anesthesia Drugs Sales Market Share by Region (2019-2024)
Table 40. APAC Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Sevoflurane Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 42. APAC Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 43. Europe Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 44. Europe Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Sevoflurane Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 46. Europe Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Sevoflurane Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 50. Middle East & Africa Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sevoflurane Anesthesia Drugs
Table 52. Key Market Challenges & Risks of Sevoflurane Anesthesia Drugs
Table 53. Key IndustryTrends of Sevoflurane Anesthesia Drugs
Table 54. Sevoflurane Anesthesia Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sevoflurane Anesthesia Drugs Distributors List
Table 57. Sevoflurane Anesthesia Drugs Customer List
Table 58. Global Sevoflurane Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 59. Global Sevoflurane Anesthesia Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Sevoflurane Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 61. Americas Sevoflurane Anesthesia Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Sevoflurane Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 63. APAC Sevoflurane Anesthesia Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Sevoflurane Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 65. Europe Sevoflurane Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Sevoflurane Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Sevoflurane Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Sevoflurane Anesthesia Drugs SalesForecast byType (2025-2030) & (K Units)
Table 69. Global Sevoflurane Anesthesia Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Sevoflurane Anesthesia Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 71. Global Sevoflurane Anesthesia Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Hengrui Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 74. Hengrui Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Hengrui Main Business
Table 76. Hengrui Latest Developments
Table 77. Baxter Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 79. Baxter Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Maruishi Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Maruishi Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 84. Maruishi Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Maruishi Main Business
Table 86. Maruishi Latest Developments
Table 87. AbbVie Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 89. AbbVie Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 94. Piramal Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. LAB UNKNOWN Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. LAB UNKNOWN Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 99. LAB UNKNOWN Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. LAB UNKNOWN Main Business
Table 101. LAB UNKNOWN Latest Developments
Table 102. Viatris Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Viatris Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 104. Viatris Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Viatris Main Business
Table 106. Viatris Latest Developments
Table 107. PT Novell Pharmaceutical Basic Information, Sevoflurane Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Portfolios and Specifications
Table 109. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. PT Novell Pharmaceutical Main Business
Table 111. PT Novell Pharmaceutical Latest Developments



LIST OFFIGURES
.
Figure 1. Picture of Sevoflurane Anesthesia Drugs
Figure 2. Sevoflurane Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sevoflurane Anesthesia Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Sevoflurane Anesthesia Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Sevoflurane Anesthesia Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Sevoflurane Anesthesia Drugs Sales Market Share by Country/Region (2023)
Figure 10. Sevoflurane Anesthesia Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Generic Drugs
Figure 12. Product Picture of Brand Drug
Figure 13. Global Sevoflurane Anesthesia Drugs Sales Market Share byType in 2023
Figure 14. Global Sevoflurane Anesthesia Drugs Revenue Market Share byType (2019-2024)
Figure 15. Sevoflurane Anesthesia Drugs Consumed in Hospital
Figure 16. Global Sevoflurane Anesthesia Drugs Market: Hospital (2019-2024) & (K Units)
Figure 17. Sevoflurane Anesthesia Drugs Consumed in Clinic
Figure 18. Global Sevoflurane Anesthesia Drugs Market: Clinic (2019-2024) & (K Units)
Figure 19. Sevoflurane Anesthesia Drugs Consumed in Other
Figure 20. Global Sevoflurane Anesthesia Drugs Market: Other (2019-2024) & (K Units)
Figure 21. Global Sevoflurane Anesthesia Drugs Sale Market Share by Application (2023)
Figure 22. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application in 2023
Figure 23. Sevoflurane Anesthesia Drugs Sales by Company in 2023 (K Units)
Figure 24. Global Sevoflurane Anesthesia Drugs Sales Market Share by Company in 2023
Figure 25. Sevoflurane Anesthesia Drugs Revenue by Company in 2023 ($ millions)
Figure 26. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Company in 2023
Figure 27. Global Sevoflurane Anesthesia Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Sevoflurane Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 30. Americas Sevoflurane Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 31. APAC Sevoflurane Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 32. APAC Sevoflurane Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 33. Europe Sevoflurane Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 34. Europe Sevoflurane Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Sevoflurane Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Sevoflurane Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 37. Americas Sevoflurane Anesthesia Drugs Sales Market Share by Country in 2023
Figure 38. Americas Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 39. Americas Sevoflurane Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 40. Americas Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 41. United States Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Sevoflurane Anesthesia Drugs Sales Market Share by Region in 2023
Figure 46. APAC Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2019-2024)
Figure 47. APAC Sevoflurane Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 48. APAC Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 49. China Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. India Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwan Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Sevoflurane Anesthesia Drugs Sales Market Share by Country in 2023
Figure 57. Europe Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 58. Europe Sevoflurane Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 59. Europe Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 60. Germany Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 61.France Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Sevoflurane Anesthesia Drugs Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Sevoflurane Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 67. Middle East & Africa Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 68. Egypt Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71.Turkey Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Sevoflurane Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sevoflurane Anesthesia Drugs in 2023
Figure 74. Manufacturing Process Analysis of Sevoflurane Anesthesia Drugs
Figure 75. Industry Chain Structure of Sevoflurane Anesthesia Drugs
Figure 76. Channels of Distribution
Figure 77. Global Sevoflurane Anesthesia Drugs Sales MarketForecast by Region (2025-2030)
Figure 78. Global Sevoflurane Anesthesia Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 79. Global Sevoflurane Anesthesia Drugs Sales Market ShareForecast byType (2025-2030)
Figure 80. Global Sevoflurane Anesthesia Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 81. Global Sevoflurane Anesthesia Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 82. Global Sevoflurane Anesthesia Drugs Revenue Market ShareForecast by Application (2025-2030)


More Publications